相似文献/References:
[1]湛海伦,高新,蔡育彬,等.腹腔镜肾癌根治术联合DC-CIK细胞免疫治疗的临床疗效[J].中华腔镜泌尿外科杂志(电子版),2007,(02):112.
ZHAN Hai-lun,GAO Xin,CAI Yu-bing,et al.Clinical efficacy of laparoscopic radical nephrectomy combined DC-CIK cells immunotherapy in renal cell carcinoma[J].,2007,(01):112.
[2]张宇,刘东,胡岚亭,等.后腹腔镜与开放肾部分切除术治疗局限性肾癌的疗效比较[J].中华腔镜泌尿外科杂志(电子版),2013,(01):9.
ZHANG Yu,LIU Dong,HU Lan-Ting,et al.Comparison of retroperitoneal laparoscopic and open partial nephrectomy in local renal cell carcinoma[J].,2013,(01):9.
[3]范大为刘凯袁成刚杜晓媛.Beclin-1在肾癌组织中的表达及其临床意义[J].中华腔镜泌尿外科杂志(电子版),2015,(02):96.[doi:10.3877/cma.j.issn.1674-3253.2015.02.004
]
Fan Dawei,Liu Kai Yuan Chenggang,et al.Expression level and clinical significance of Beclin-1 in renal cell carcinoma[J].,2015,(01):96.[doi:10.3877/cma.j.issn.1674-3253.2015.02.004
]
[4]曹翔 甘卫东.Xp11.2 易位/TFE3 基因融合相关性肾细胞癌的认知[J].中华腔镜泌尿外科杂志(电子版),2014,(05):374.[doi:10.3877/cma.j.issn.1674-3253.2014.05.015
]
[5]加素尔 ?吐尔,徐铭泽,唐钵,等.广东省医学会泌尿外科疑难病例多学科会诊（第14期）——左肾原发罕见恶性肿瘤并全身多处转移[J].中华腔镜泌尿外科杂志(电子版),2024,18(01):110.[doi:10.3877/cma.j.issn.1674-3253.2024.01.021]
[J].,2024,18(01):110.[doi:10.3877/cma.j.issn.1674-3253.2024.01.021]